Analyst Conference Summaries

Biotechnology Investor Aids

2seventy bio

conference date: November 14, 2023 @ 5:00 AM Pacific Time

2seventy bio a Buy for Abecma and CAR T Platform [December 9, 2022 at Seeking Alpha]

2seventy bio Prospects [August 23, 2022 at Seeking Alpha]

TSVT Q4 2022
Press Release
2seventy bio
Q1 2023
2seventy bio
Q2 2023
2seventy bio
Q3 2023
March 16, 2023 May 3, 2023 Aug. 14, 2023 Nov. 14, 2023
      TSVT Q3 2022
Press Release
      Nov. 7, 2022

2seventy bio (TSVT) is a biotechnology company specializing in CAR-T therapies.

2seventy bio web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2023 William P. Meyers